Patent · US Active

Expression system

US9994622B2 · kind B2 · utility

3Cited by

1References

29Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Normand Blais · Laval, CA
Philippe Marc Helene Dehottay · Rixensart, BE
Marianne Dewerchin · Rixensart, BE
Philippe Goffin · Louvain-la-Neuve, BE
Denis Martin · Laval, CA

Key dates

Filing date	Jul 14, 2016
Grant date	Jun 12, 2018
Priority date	—
Expiry date	Jul 14, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/034
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Compositions and methods related to periplasmic expression of a toxin including diphtheria toxin or CRM197 are provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.